Clinical Trial Update: Open-Label Study to Evaluate the Long-Term Safety and Efficacy of VI-0521 in Type 2 Diabetic Adults [Phase 2]

View source ↗

Summary

Open-label Phase 2 study assessing long-term safety and efficacy of VI-0521 in adults with Type 2 diabetes; the trial was terminated with results posted in 2012…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• VI-0521

Snippet

Sponsor: VIVUS LLC | Conditions: Diabetes | Phase 2 | Status: TERMINATED | Results posted: 2012-09-03